Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma
Conditions
Sinonasal Squamous Cell Carcinoma · Stage III Sinonasal Cancer AJCC v8 · Stage IVA Sinonasal Cancer AJCC v8 · Stage IVB Sinonasal Cancer AJCC v8
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California, United States
Contact: Principal Investigator (Edward Kuan)UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States
Contact: Principal Investigator (Edward Kuan)Emory University Hospital Midtown, Atlanta, Georgia, United States
Contact: Principal Investigator (Jose A. Monteiro de Oliveira Novaes)University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States
Contact: Principal Investigator (Dan P. Zandberg)
Study leads
Siddharth Sheth
Principal Investigator
Ohio State University Comprehensive Cancer Center LAO